# US 2016/0256574 A1 · Method and apparatus for kidney function analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256574 A1
- Document ID: US20160256574A1
- Status: Published application
- Kind: A1
- Application number: 15/155,391
- Filed: 2016-05-16
- Published: 2016-09-08
- Earliest claimed: 2005-04-19
- Assignees: Indiana University Research and Technology Corporation
- Applicants: Indiana University Research and Technology Corporation
- Inventors: Weiming YU; Bruce A. MOLITORIS; Ruben M. SANDOVAL
- Web page: https://patentgrep.com/patent/US20160256574A1

## CPC

- A61K 49/0004: {Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions}
- A61K 49/0032: {Methine dyes, e.g. cyanine dyes}
- A61K 49/0041: {Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal (in vivo G01N)}
- A61K 49/0043: {Fluorescein, used in vivo}
- A61K 49/0054: {Macromolecular compounds, i.e. oligomers, polymers, dendrimers}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A method and apparatus for determining physiological data related to an animal, such as kidney diagnostics data, is provided. The method includes injecting a mixture of a first and a second molecule into an animal (e.g., a human patient), determining a molecular ratio of the molecules, and determining the physiological data based on the molecular ratio. The apparatus includes a number of finger receiving apertures, a light generation circuit, a light detection circuit, a pulse counting circuit, and a user interface.

## Claims

### Claim at position 1

-45. (canceled)

### Claim 46

A method for determining the molecular filtration resistance (ξ) of a first molecule by an organ in an animal, the method comprising:
a) determining the rate constant of body compartment clearance (k) in the animal, said determination comprising:
administering the first molecule and a second molecule into the body compartment of the animal, wherein the organ clears the second molecule from the body compartment at a rate lower than the rate at which the organ clears the first molecule from the body compartment;
determining the molecular ratio (RB/RA) of the first molecule to the second molecule in the body compartment over a period of time to obtain a time series of molecular ratios ((RB/RA)(t)), the molecular ratio (RB/RA) being determined using the following equation:
RB/RA=IB/IA,
wherein IB is the level of the first molecule in the body compartment and IA is the level of the second molecule in the body compartment; and
performing a least square fitting of the time series of molecular ratios ((RB/RA)(t)) to obtain the rate constant (k) of body compartment clearance using the equation:
(RB/RA)(t)=c+a *exp(−kt)
wherein c is a constant, a is a pre-exponential factor, and t is time;
b) determining the glomerular filtration rate (GFR) of the organ of the animal; and
c) determining the molecular filtration resistance (ξ) of the molecule using the following equation:
ξ=(k2*Vplasma)/GFR
wherein Vplasma is the plasma volume of the animal.

### Claim 47 (depends on 46)

The method of claim 46, wherein the first molecule is a protein.

### Claim 48 (depends on 46)

The method of claim 46, wherein the body compartment is the vascular system of the animal.

### Claim 49 (depends on 46)

The method of claim 46, wherein the organ is selected from the group consisting of the kidney, the liver, the lung, the spleen, the pancreas, the brain, the heart, the muscle, and the intestine.

### Claim 50 (depends on 46)

The method of claim 46, wherein the body compartment clearance of the organ is due to at least one of filtration, reabsorption, osmosis, metabolism, and active secretion.

### Claim 51 (depends on 46)

The method of claim 46, wherein the level of the first molecule is determined based on the intensity of a signal generated by the first molecule and the level of the second molecule is based on the intensity of a signal generated by the second molecule.

### Claim 52 (depends on 51)

The method of claim 51, wherein the signal generated by the first molecule is of a type different than the signal generated by the second molecule.

### Claim 53 (depends on 51)

The method of claim 51, wherein the signal generated by the first molecule and the signal generated by the second molecule are selected from the group consisting of fluorescence, a scattering signal from incident light, fraction of fluorescence lifetimes, absorbance, and polarization.

### Claim 54 (depends on 46)

The method of claim 46, wherein the first molecule and the second molecule are administered in a mixture.

### Claim 55 (depends on 46)

The method of claim 46, wherein the molecular ratio (RB/RA) of the first molecule to the second molecule is replaced by the generalized polarity (GP) of the first molecule and the second molecule, the generalized polarity (GP) being determined using an equation selected from the group consisting of:
GP=(IA−IB)/(IA+IB)
and
GP=(IB−IA)/(IA+IB),
wherein IA is the level of the second molecule in the blood and IB is the level of the first molecule in the blood.

### Claim 56 (depends on 51)

The method of claim 51, wherein the molecular filtration resistance of the first molecule has a value of about 1.

### Claim 57 (depends on 51)

The method of claim 51, wherein the second molecule is a fluorescent labeled molecule having a molecule weight of greater than 70 kD.

### Claim 58 (depends on 51)

The method of claim 51, wherein the second molecule has a molecular weight greater than the first molecule.

### Claim 59 (depends on 46)

The method of claim 46, wherein at least one of the first and the second molecules is a sugar with left-hand chirality.

### Claim 60 (depends on 46)

The method of claim 46, wherein the first and second molecules are fluorescent probes.

### Claim 61 (depends on 60)

The method of claim 60, wherein determining a molecular ratio includes determining a fluorescent intensity ratio of the first and second molecules.

### Claim 62 (depends on 46)

The method of claim 46, wherein the total blood plasma volume, Vplasma, is determined based on an average whole blood volume.

### Claim 63 (depends on 46)

The method of claim 46, wherein the total blood plasma volume, Vplasma, is determined using the following equation:
VD=Vbefore*[IL]before/[IL]plasma
wherein VD is the total blood plasma volume, Vbefore is a volume of the second molecule prior to the injecting step, [IL]before is a total fluorescent intensity value of the second molecule prior to the injecting step, and [IL]plasma is a total fluorescent intensity value of the second molecule subsequent to the injecting step.
